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Abstract The detection of genetically modified (GM) materi-
als in food and feed products is a complex multi-step analytical
process invoking screening, identification, and often quantifi-
cation of the genetically modified organisms (GMO) present in
as a m p l e .“Combinatory qPCR SYBR®Green screening”
(CoSYPS) is a matrix-based approach for determining the
presence of GM plant materials in products. The CoSYPS
decision-support system (DSS) interprets the analytical results
of SYBR®GREEN qPCR analysis based on four values: the
Ct-a n dTm values and the LOD and LOQ for each method. A
theoretical explanation of the different concepts applied in
CoSYPS analysis is given (GMO Universe, “Prime number
tracing”, matrix/combinatory approach) and documented
using the RoundUp Ready soy GTS40-3-2 as an example.
By applying a limited set of SYBR®GREEN qPCR methods
and through application of a newly developed “prime
number”-based algorithm, the nature of subsets of corre-
sponding GMO in a sample can be determined. Together,
these analyses provide guidance for semi-quantitative estima-
tion of GMO presence in a food and feed product.
Keywords GMO.Screening.Primenumber.qPCR.
SYBRGreen
Introduction
At a global level, more than 100 genetically modified
organisms (GMO) have received an authorization for com-
mercial usage as food or feed (http://www.gmo-compass.org,
http://www.agbios.com/dbase.php). As such, GMO represent
an important component of the global food and feed market,
and enforcement legislation has been put into place to verify
compliance with the local regulations. As an example, testing
of materials derived from food and feed materials is
regulated in Europe through the EC Regulations EC/2003/
1829 and 1830 [1, 2]. Due to existence of differences in local
GMO legislations and the global nature of the food and feed
market, asynchronously authorized GMO are more and more
appearing on the market, invoking specific decisions at the
local level in case of infringement (e.g., LL601 and Bt63 rice
in the EC) [3, 4]. With respect to the market introduction of
GMO, many countries, including the EC, have installed a
government policy supporting a strong commitment to
consumer protection and freedom of choice [1, 2]. For this,
the traceability and/or labeling of GM products along the
food chain are critical. At the EC level, two particular
concepts have been elaborated to support such policy: (1) the
amount of GMO is to be calculated per ingredient (defined
as a “taxon”, e.g. soy, maize, etc.), and (2) product labeling is
mandatory when exceeding a threshold level of GMO (above
0.9% GMO per ingredient) [2]. Inview ofthe diversity of the
GM-market (from grain to pizzas), the EC recommended to
apply the “Haploid Genome Equivalent” (HGE) as the
standard DNA detection unit for all GM food/feed products
[5].
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market, the first step in GMO analysis consists in general of
screening for presence of GMO. The establishment of a
GMO screening approach requires the availability of (1)
appropriate detection methods (with adequate performance,
scope, and legal basis), (2) suitable reference materials, and
(3) a DSS. Moreover, such an approach should preferen-
tially apply a familiar technology in GMO analysis (such as
“Polymerase Chain reaction” (PCR) [6]) and be suited for
flexible adaptation to the market reality and the client needs
in a cost-efficient way. The enforcement activities are, to
date, primarily focusing on DNA-based approachesofwhich
the vast majority applies PCR. Several GMO screening
approaches, mostly based on real-time PCR (qPCR) or
micro-arrays,havealreadybeen developed aiming atcovering
suchbroadrangeofGMOwithaminimalnumberofanalyses.
For a recent critical review of those technologies, we refer to
the article of Querci et al. [7]. To date, only the so-called
Dualchip array is readily commercially available [8–10].
Most of the enforcement laboratories have today already a
(costly) qPCR platform in place, but many of these novel
technologies may require additional investments in new
equipment, in technology validation, and in logistic support.
It is thus considered the most appropriate to exploit further
qPCR-based screening approaches (see also Querci et al. [7]
for a more elaborate discussion).
In setting up a GMO screening that meets the above
criteria, it was considered that SYBR®Green qPCR could
offer a good alternative with a number of advantages over
the other PCR-based approaches: (1) SYBR®Green qPCR
monitors the increase in total fluorescence throughout the
amplification, allowing to estimate the presence of non-
specific amplification, (2) the melting temperature analysis
allows post-PCR verification of the amplification of the
expected target and any closely related target(s), (3) the
SYBR®Green technology is more cost-effective as no dye-
labeled oligonucleotide probes are required [11].
For this, the “Combinatory SYBR®GREEN qPCR
Screening” (abbreviated as “CoSYPS”)w a sd e v e l o p e d
for the commonly applied 96-well plate qPCR format,
supported by a matrix-based interpretation of the analyt-
ical results. Here, we present the theoretical background
to the key concepts as applied in CoSYPS: the “GMO
Universe”, the matrix-based screening, and the use of
“prime-number GMO tagging” in facilitating selection of
the possible GMO present in the sample. Next, the
combinatory interpretation of the analytical results based
on four analytical values (the Ct,t h eTm,t h e“LOD6” and
the “LOQ6”) is explained. Each of these concepts is
documented by using the RoundUp Ready® soy GTS40-
3-2 as a model. Finally, future perspectives on the use, the
development, and the integration of CoSYPS into a
complete GMO detection platform are discussed.
General description of the field of application
GMO analysis for enforcement is a complex process
addressing the compliance of food and feed products with
the legal requirements for GMO use. To formally describe
the CoSYPS approach, the following elements needed
either to be newly developed, either to be described within
the context of the CoSYPS approach:
1. The formal description of a GMO in terms of their
detection targets,
2. The concept of a “Universe” for GMO,
3. An illustration of the matrix-based screening approach,
4. A mathematical GMO tagging, based on prime numbers,
5. The decision criteria applied in CoSYPS (Ct, Tm, LOD,
and LOQ)
6. The principles in combinatory decision taking
The first three items are considered to represent key
concepts that are driving the general understanding of the
principles in a matrix-based screening approach. These
concepts are presented in the glossary part below. The fourth
topic represents a novel developed mathematical way of
identifying the possible GMO present in a sample based on
the outcome of the screening results. In the last two points,
the experimental parameters used specifically as decision
criteria in CoSYPS are outlined and the principles in the
combinatory interpretation within CoSYPS are explained.
Glossary to general concepts in GM plants (GMP)
screening analysis
Concept 1: Description of a GMP in function of the
constituents of the genetic modification
All EU-authorized GMO for food and feed use, represent
plant or microbial transformation events that resulted from
the introduction of a specific DNA sequence into the
genome of a host species (1, 2, and 3). Here, we will only
discuss the genetically modified plants (GMP), but a similar
reasoning can hold for any other set of GMO (such as
bacteria or viruses). In the GMP engineering process, a
certain transformation vector with known molecular DNA
structure is being constructed and used for the introduction
of new traits in a host plant. The precise organization and
content of the newly introduced DNA sequences in the
GMP are determined through detailed molecular analysis of
each GMP (e.g., by Southern blot analysis, PCR analysis,
and ultimate DNA sequence analysis). All this information
is comprehensively documented in the official registration
files required to obtain an authorization of use of the GMP
in the EC (1, 2, and 3).
The DNA introduced after transformation (designated
as “TransDNA”) can be described in a “1×Zi” linear
2114 M. Van den Bulcke et al.matrix format in which Zi represents the respective
(relevant) DNA elements of the transformation vector
and ai the number of copies of that element (see left
panel):
 
     
 
 
As an example, the TransDNA for the RoundUp Ready®
soy GTS40-3-2 is described as a function of three vector
elements (here the p35S, tNOS, and CP4-EPSPS; see right
panel). Typical relevant TransDNA elements can thus in
general be transcription regulatory sequences (e.g. the
CaMV 35S and Agrobacterium NOS promoter and termi-
nator …), “Open Reading Frames” (ORF) (e.g. CryIAB,
PAT/bar…) or so-called vector-specific elements compris-
ing sequences from two different kinds of elements (such as
the 35S-bar [3] or CryIAb-Nos [4]).
When combined with host plant taxon-specific elements
(e.g. lectin (soy), alcohol dehydrogenase (maize),…)a n ds o -
called event-specific elements (e.g. junction fragments be-
tween transformation vector DNA and ‘flanking’ plant
genome DNA (http://gmo-crl.jrc.ec.europa.eu; CRL-GMFF)),
a unique linear matrix can be developed for each GMP.
Concept 2: Definition of the “EU-GMP Universe” in time
and space
Next, the set of GMP to be analyzed can be defined by the
mathematical concept “Universe”,b e i n g“a class that contains
(as elements) all the entities under consideration in a given
situation”.I nT a b l e1, a general representation in a table
format is shown. The different GMP are represented by the
rows, the constituents are listed in the columns. In this
example, the GMP Universe comprises five GMP(X1–5),
while the targets (z1–4) represent DNA sequences within the
corresponding constituents Z1–4 detected by the methods m1–4.
With respect to the EU enforcement world, the most
relevant “Universe” would be the authorized GM plants to
be placed on the market (EC directive EC/2001/18) [12],
and authorized as GM food/feed (EC regulation EC/2003/
1829) [1]. This set of GMP will be further denoted as the
“EU-GMP Universe” (EU-GMP). An example of a repre-
sentation of this Universe is shown in Table 2. Herein, the
following constituents are listed: the species/taxon in
column A, the event-specific element in column B and
generic recombinant elements (such as transcription ele-
ments, vector-specific elements…) and GM-trait DNA
elements in columns C to S. Each GMP is then represented
as a single row in the table by a linear ‘1×19’ matrix and
the EU-authorized GM plant Universe-Anno 2009 (includ-
ing the legal decisions on some unauthorized GMP)
Table 1 GMP analysis interpretation according to a matrix-based
approach
Method 
m1
Method 
m2
Method 
m3
Method 
m4
Target z 1 Target z 2 Target z 3 Target z 4
GMP X1 x x 
GMP X2 x  x 
GMP X3 x 
GMP X4 x x 
GMP X5 x x 
The formal logical decision path when screening a sample potentially
containing GMP X1–5 with "Method m2 is indicated in gray (“x”:
target is present in GMP Xi; “” : target is not present in GMP Xi)
 
   
 
   
 
 
 
An introduction to “Combinatory SYBR®Green qPCR Screening” 2115comprising 29 GMP (omitting any of the stacked events),
can be described by a “29×19” matrix.
Concept 3: “Matrix-based” GMP screening approach
by establishing a formal relation between
analytical results and GMP presence
through validated detection methods
In general, the first step in GMP analysis consists of a
generic screening for the presence of GMP in a sample (for
a review see, [13]). In the ideal situation, such screening
should allow to detect all GMP of the GMP Universe. In
setting up a minimal format (being the least number of
methods required to detect the most of the GMP in the best-
discriminating way), the matrix description of the GMP
Universe can serve in determining (1) the frequency of
presence of the different targets in the GMP (= “coverage”
power) and (2) the relative distribution of the respective
targets in the GMP (= “discriminative” power).
In GMP, the most commonly present GM targets are the
CaMV 35S promoter (p35S) and the Agrobacterium NOS
terminator (tNOS; see Table 2), which have accordingly
been very often used in GMP screening. Limiting the initial
screening to those common targets only, has the disadvan-
tage that the presence/absence of large numbers of GMP
needs to be confirmed in a second GM identification
analysis. Adding GMP discriminating targets (e.g. endog-
enous targets, GM-trait targets) to the initial screening can
however greatly reduce the number of possible GMP.
Having defined a set of targets suited to detect the GMP
in a particular Universe, the basic principle in matrix-based
screening analysis requires establishing a formal relation D
which stipulates the detection of a particular target in a
GMP by an analytical method (see Box below).
The formal relation D may contain, in principle, any
detection method used in GMP analysis that meets the
validation criteria set by the ISO norm 5275 [14] and/or, at
least in the EU, the ENGL guidelines [15]. Here, as an
example, the EU-GMPsoy Universe is described, which to
date contains three authorized GMP in casu GTS40-3-2,
A2704-12, and MON89788 (see Table 2).
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An introduction to “Combinatory SYBR®Green qPCR Screening” 2117When applying such relationship in a GMP analysis (see
Table 1), any positive signal (target per definition present
“≥LOD”) obtained with a validated method for a particular
target indicates that GMP comprising this target could be
present in the sample, as indicated by the x correlation in the
matrix. If the target cannot be detected (<LOD), an “empty”
is annotated. When multiple GMP comprise the same target
(see, e.g. target z2 in Table 1), a positive result generated by
screening with method m2, indicates that the GMP X2 and
X4 could be present in that sample (see gray fields in
Table 1). This principle represents the key algorithm to the
matrix-based approaches developed in GMP screening. A
similar reasoning holds when multiple methods are being
used in a screening approach (see example below).
Mathematical GMP “tagging” and selection through “Gödel
Prime Product” modulation
The aim of COSYPS analysis is to obtain sufficient
information allowing predicting the set of GMP present in
a sample. Given the constant increasing number of GMP, a
numerical tag of each GMP would be an asset in
developing a simple mathematical way of identifying each
GMP. In most models, the presence of a target is
mathematically converted into “1”, while absence is
indicated by “0”. Although very simple and directly linked
to the binary computer system and logical truth functions,
the use of such description is limited to binary interpreta-
tion requiring handling large data arrays by informatics
programs for interpretation of the outcomes. In the
mathematical model supporting CoSYPS, a novel target
identifying concept based on prime numbers has been
introduced. Prime numbers have by definition only two
dividers, the prime number itself and “1”. As such, not only
can these numbers be used as a true/false function similar to
the binary “1/0” combination, the choice of a different
prime number for each element/target/method provides a
specific representation of each of them.
In CoSYPS analysis, a unique prime number PmK is thus
assigned to each particular screening qPCR method/target
combination (see Table 3). When the target is present in the
GMP and a positive signal is obtained when applying
qPCR method mk, instead of a x, the corresponding prime
number PmK is assigned to that relationship. When the
qPCR/target combination is absent in the GMP (“empty” in
Table 1), a “1” is assigned, “1” being the neutral element in
the multiplication.
GPPXi ½  ¼ Π PmK   PSp   PEvh ð1Þ
Wherein
PmK Prime number of the method mk recognizing a
vector element zk in Xi
PSp Prime number of the method recognizing the species
DNA element in Xi
PEvh Prime number of the method recognizing an event-
specific element in Xi
When a certain set of screening methods is then applied (in
the example in Table 3, the methods m1–4), each GMP can
be represented by product of the different PmK of the
respective methods that recognize a target comprised in this
GMP (see last column in Table 3). This product is
designated the “Gödel Prime Number” of the GMP Xi
(=GPPXi) and represents a “mathematical tag” for this GMP
in a particular GMP Universe [16]. From this GPPXi the
different elements present in a GMP Xi can be obtained
through factorization into it’s the dividers (= Central
theorem of natural numbers). Vice versa, dividing the
GPPXi by the primes of the respective qPCR/target
combinations used to compile the GMP Universe will, as
a consequence of the nature of prime numbers, always yield
an integer number whenever the target is present in that
GMP. If the target is not present, a non-integer number will
be obtained as the quotient. Thus, the presence of a target in
a GMP can be mathematically traced as generating an
integer quotient by the following division:
GPPXi=PmK ¼ integer : Target zk is present in GPPXi
GPPXi=PmK 6¼ integer : Target zk is absent from GPPXi
ð2Þ
In a similar way, when using multiple methods in a
screening approach, the product of the prime numbers of
the positively scored screening outcomes for a sample can
be represented by “GPPSample” product (see Table 4). This
number comprises the targets that are detectable (≥LOD) in
the sample, and the GPPSample can be used as a divider to
search for the GMP present in the sample in a similar way
as in Eq. 2:
GPPSample=GPPXi ¼ integer : GPPXi is possibly present in the sample
GPPSample=GPPXi 6¼ integer : GPPXi is not detected in the sample
ð3Þ
Thus, based on the GPPXi of the respective GMP present in
the EU-GMP and the outcome of the screening analysis,
expressed as the GPPSample, the possible presence of a GMP
can be easily determined by a simple division function.
In Table 4, the outcome of screening four different
samples S1–4 the methods m1–4 is shown. In S1, 2, and 4,
the GPPSample/GPPXi quotient yields an integer number for
some GMP, indicating that these GMP may be present in
that sample. In sample S3, none of the GPPSample/GPPXi
quotients yield an integer, indicating that none of these
GMP is detectable in this sample. Such a “prime number”-
based tagging of the respective GMP allows thus for an
2118 M. Van den Bulcke et al.easy interpretation of the analytical results in terms of GMP
present in a sample. An example is shown in Tables 5 and 6
for the RR soy GTS40-3-2 using the {qPCR methods} =
{LEC, p35S, tNOS, CP4-EPSPS, PAT}. The EU-GMPsoy is
used as universe (see above). In the upper panel, a prime
description of this Universe is presented; in the lower panel,
the outcome of a “prime number” tracing analysis on three
(theoretical) samples is shown. In two samples, the
outcome shows that RRsoy can be present (integer quotient;
S2 and S3), in one sample no GMsoy can be detected (S1).
The four CoSYPS decision parameters: the Tm value, the Ct
value, and the LOQ6 and LOD6 values
Next to providing a mathematical tool for formal interpre-
tation of the outcome of a screening analysis, the criteria
allowing assigning a particular decision value to a
measurement are to be defined. CoSYPS analysis deter-
mines the presence of GMP, based on the presence of
(preferentially) multiple elements comprised in a GMP by
qPCR analysis. As these elements are linked in the
transformation event, each of the elements comprised in a
GMP should be positive in the qPCR profile in order to
conclude the presence of that particular GMP. In CoSYPS,
four values for each target are taken into consideration: the
Tm value, the Ct value, and the LOQ6 and LOD6 values.
Taking a correct Tm value as the primary criterion, a
qPCR measurement in a sample analysis is considered to be
matching the relationship D for a certain target in a sample
only when: (1) a peak upon melting analysis is obtained
with a Tm value corresponding to the nominal Tm value
obtained with the reference material as template DNA (with
an acceptable SD±1°C), and (2) an (exponential) amplifi-
cation above the threshold level can be measured (=a Ct
value). The nominal Tm value for each target has been
determined by melting curve analysis upon cloning the
amplicons into a uniform plasmid background, the “Syb-
ricon” plasmids [17]. In this way, the influence of
background surroundings is considered to be minimized in
comparison to genomic DNA backgrounds.
Next, the amount of target present in the sample,
represented by the Ct value in qPCR analysis, is taken as
the second decision criterion in CoSYPS. In this respect,
two quantity-based decision levels are defined: the “LOD6”
and the “LOQ6”. The lower level of detection (here
designated as the “LOD6”), is estimated essentially accord-
ing to the former AFNOR Norm XP V03-020-2 [18] and
the IUPAC guidelines [19]. The “LOD6” of a qPCR method
represents the minimal number of targets required in a
sample to obtain six of six positive signals at a sixfold
repetition of the qPCR analysis on that sample. This LOD6
represents, as such, the (estimated) HGE (measured in
qPCR by the Ct value), at which level, within a linear serial
dilution analysis, each of the 6 repeats provides a positive
signal (n=6; six of six positive signals). All qPCR methods
applied in a CoSYPS approach should (preferentially) yield
an LOD6 of about two to ten target copies in order to meet
the requirements of the ENGL [15].
Method m1 Method m2 Method m3 Method m4
Target z1 Target z2 Target z3 Target z4
3 5 7 11 GPP Xi
GMO X1 317 1 2 1
GMO X2 351 1 1 5
GMO X3 311 1 3
GMO X4 157 1 3 5
GMO X5 311 1 1 3 3
Table 3 Conversion of “x”/“”
Matrix into “Prime Number”
Matrix (as a basis the matrix in
Table 1 was taken)
GPP Xi Gödel prime product of
the GMP Xi
Table 4 Mathematical “Prime number"-based GMP tracing in samples S1–4
Sample GPPsample GMP X1 GMP X2 GMP X3 GMP X4 GMP X5
21 15 3 35 33
S1 15 0.71428571 1 5 0.42857143 0.45454545
S2 21 1 1.4 7 0.6 0.63636364
S3 77 3.66666667 5.13333333 25.6666667 2.2 2.33333333
S4 165 7.85714286 11 55 4.71428571 5
S1 possibly contains GMP X2 and 3
S2 possibly contains GMP X1 and 3
S3 does not contain any of the GMPs
S4 possibly contains GMP X2, 3 and 5
An introduction to “Combinatory SYBR®Green qPCR Screening” 2119In view of the necessity to obtain quantitative data on the
GMO presence for labeling purposes, an additional level of
quantity was determined the so-called “LOQ6”. In this case,
the minimal amount of copies of target (designated
“LOQ6”) present in 5 μl DNA extract in order to obtain a
consistent analytical result (accepted SD±0.5 Ct) for six
repeated measurements was determined for each qPCR
method. This LOQ6-based decision criterion applied in
CoSYPS is, as such, a more quantity-based threshold. The
LOQ6 was determined through SYBR®Green qPCR anal-
ysis on (low-bias) single-copy target genomic DNA (e.g.
gDNA from leaf tissue of homozygous/hemizygous seeds
with certified HGE for the target). All qPCR methods
should (preferentially) have an LOQ6 of about 20 target
copies in the CoSYPS set-up [15].
The Ct values corresponding to the LOD and LOQ6 as
determined on the single-copy target genomic DNA, are
retained per se as decision values in the CoSYPS decision-
support system.
Combinatory interpretations in CoSYPS analysis
In practice, sampling for enforcement purposes on GMO
presence is performed by government officials and a
laboratory sample is prepared according to standardized
protocols (such as described in [5]). This laboratory sample,
typically about 500 g to 1 kg, is at first homogenized by the
analyzing laboratory and at least two representative
analytical samples (between 250 mg to 1 g, depending on
the nature of the sample) are extracted and analyzed using a
set of SYBR®Green qPCR methods. Each subsample is
herein analyzed once for the presence of the respective
“CoSYPS” targets in the sample.
The combinatory data interpretation within CoSYPS lays
at three levels: (1) a combined evaluation of the Tm and Ct
values for the presence of a certain target in each analysis of
a subsample, (2) the combined evaluation of the outcome
for the presence of a certain target in two subsamples, and
(3) the combined evaluation of the presence of multiple
targets for the determination of the presence of a particular
GMP.
Level 1: Evaluating the Tm and Ct value for each target in
each subsample
The primary criterion in CoSYPS is the Tm value
obtained upon melting analysis of the PCR amplification
products. Any Tm signals falling out of the range of the
acceptance criteria for a particular qPCR method (set at the
a priori determined nominal value±1 °C), will not be
retained for further analysis. Applying the Ct values
corresponding to the LOQ6 and LOD6 (semi-quantitative)
scores for each method, allows establishing a semi-
quantitative decision for each target with an acceptable Tm
value.
Level 2: Combining the analytical results of for each
target in the two subsamples
The possible outcomes of the analysis of two subsamples
for each qPCR method using the CoSYPS decision criteria
LOD6 and LOQ6 are listed in Table 7. In principle, each
target that is present “≥LOD6” will be retained in the
CoSYPS evaluation and the corresponding prime number
of that target will be comprised in the GPPSample (see
Table 8 (upper panel)). For each qPCR method, three types
of outcome can thus be obtained based by the combined
interpretation of the analysis of the two subsamples: the
target is present in both subsamples “above or equal to
LOQ6” (≥LOQ), “above or equal to the LOD6” (≥LOD), or
“Below the LOD6” (<LOD). The interpretation of the
combined screening results may require additional verifi-
cation/confirmation if different outcomes are obtained for
different targets comprised in the same GMP (e.g. “≥LOQ”
in subsample A and “≥LOD” for the same marker). Such
verification is especially important when the result may
Target/Method RBCL LEC P35S CP4-EPSPS PAT
Prime 3 5 7 11 13 GPP XI
GTS40-3-2 3 5 7 11 1 1155
A2704-12 3 5 7 1 13 1365
MON89788 3 5 1 11 1 165
Table 5 Formal detection of
RR soy GTS40-3-2 presence in
a sample by “Prime Number”
tagging
Table 6 Formal detection of RR soy GTS40-3-2 presence in a sample by “Prime Number” tracing
RBCL LEC P35S EPSPS PAT GTS40-3-2 A2704-12 MON89788
Primes 3 5 7 11 13 GGP 1155 1365 165
Sample GPPsample
S1 3 5 7 1 1 165 0.14285714 0.12087912 0.0008658
S2 3 5 7 7 1 1155 1 0.84615385 0.00606061
S3 3 5 7 1 13 15015 13 11 0.07878788
2120 M. Van den Bulcke et al.have an impact on the final legal decision (e.g. labeling
requirement (at LOQ), GMP presence (at LOD)). To date,
all samples with diverging decisions on combined targets
are re-analyzed and a decision is taken according ISO-
standard 24276 [20].
Level 3: Combinatory interpretation of the analytical
results for multiple targets present in a GMP
Finally, the combined outcome of the CoSYPS screening
is compared to the respective GMP of the EU-GMP
Universe, applying the “Prime number”-based GMP-
tagging algorithm. As all targets in a particular GMP are
linked, the outcome in each subsample sample should be
coherent for each target comprised in that GMP. “Coher-
ence” here means that for one GMP to be present, all targets
comprised in that GMP should be at least detectable at the
level of the least represented target in the sample. Indeed, as
some targets are present in multiple GMP or in multiple
copies in the same GMP, overrepresentation of certain targets
in a combined evaluation may occur.
For this, the CoSYPS algorithm retains all prime
numbers of the targets wherein all constituents are
present “≥LOD6”, and multiplies these to obtain the so-
called “GPPSample”. Dividing this GPPSample by the GPP
of each of the GMP of the EU-GMP Universe, allows
assessing the presence of the GMP based on the integer
nature of the quotient (see Table 8 (lower panel)). The
mathematical and logical combination of the outcome of
the respective qPCR methods based on the presence (Tm
value) and the amount (Ct value) can be organized in a
two-worksheet Excel-based model, that can be (relatively)
easily adapted to cover different scopes (at species level),
new GM-events and additional GM-screening elements
(data not shown).
ThepresenceofeachofthematchingGMPistheninanext
step of the process to be confirmed by event-specific
identification (ID). All GMP detected in the ID analysis are
thentobetestedforconformitywiththelabelingrequirements
whenever all targets of a GMP are scored “≥LOQ” These
conditions are considered reflecting to the best the require-
ments imposed by the EC legislations to date. If none of the
GMP present in the universe can explain the presence of one
or more targets, it can be concluded that a sample contains
unassigned quantities/presence of that particular target.
Further analysis will then have to be conducted as to identify
the origin or the nature of the materials generating these
unassigned signals (e.g. originating from donor organisms
(bacteria,viruses,plant…) orunauthorizedGMO).Especially
in the latter case, complex additional analyses might be
required which are outside the scope or capacity of enforce-
ment activities and will not be discussed here further (e.g.
genome walking, DNA sequencing…).
Conclusions and future perspectives
CoSYPS represents a novel real-time qPCR GMP
analysis approach based on SYBR®Green technology
Table 8 Combinatory “Level 3” evaluation according to CoSYPS analyses for Sample 2 in Table 4
Sample 1 Method m1 Method m2 Method m3 Method m4 GPP GGPSAMPLE1/GPP Conclusion
Prime 3571 1
Screening outcome Target z1 Target z2 Target z3 Target z4
SB1 >LOQ <LOD >LOQ <LOD
SB2 >LOQ <LOD >LOQ <LOD
Conclusion >LOQ <LOD >LOQ <LOD
PRIME CONVERSION 3171
GGPSAMPLE1 21
GPP EVALUATION:
GMP X1 21 1 Possibly present
GMP X2 15 1.4 No match
GMP X3 3 7 Possibly present
GMP X4 35 0.6 No match
GMP X5 33 0.63636364 No match
Sample Case 1 Case 2 Case 3 Case 4 Case 5 Case 6
Subsample A ≥LOQ ≥LOQ ≥LOQ ≥LOD ≥LOD <LOD
Subsample B ≥LOQ ≥LOD <LOD ≥LOD <LOD <LOD
Outcome ≥LOQ ≥LOD ≥LOD ≥LOD <LOD <LOD
Table 7 qPCR result “Level 2”
evaluation in CoSYPS for a
single target in the two
subsamples
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tially a matrix-based approach aiming to identify the
potential presence of GMP in a sample. CoSYPS
combines for this purpose the analytical results (Tm-
and Ct v a l u e s )o fal i m i t e ds e to fS Y B R ® G r e e nq P C R
methods with preferentially similar performance under the
same conditions. While other technologies are also
suitable to be applied in a matrix-approach, SYBR®Green
detection offers the advantage of verification of the
amplification products (based on the outcome of the
melting analysis). Two decision thresholds, the LOD6
and the LOQ6, allow then to estimate the level of GMP
present in a sample in a semi-quantitative way. The
CoSYPS DSS can be developed in an Excel format
wherein all concepts are integrated through simple logical
and mathematical functions (own unpublished data).
As such, CoSYPS is considered a versatile, cost-
effective approach in assessing the presence of GMP,
particularly useful in routine analysis for enforcement.
Further improvement of the CoSYPS may be (1) stream-
lining the SYBR®Green technology with other qPCR
technologies (e.g., Taqman…), (2) adapting the DSS
format to enable statistically valid analysis at low-level
presence of GMP, and (3) developing a CoSYPS
informatics tool which can be (easily) updated and
electronically verified, and moreover made available to
a broad range of stakeholders.
An integrated DSS for COSYPS screening and GM-event
Taqman identification
To date, the confirmation on the final set of GMP identified
to be possibly present in a sample by CoSYPS is obtained
by identification analysis applying validated event-specific
Taqman qPCR methods (http://gmo-crl.jrc.ec.europa.eu;
CRL-GMFF). Recently, the so-called pre-spotted plates
were developed allowing detecting all EU-regulated GMP
using Taqman qPCR methods adapted from the official
event-specific methods [21]. Such approach could be
readily combined with a CoSYPS analysis, although the
statistical model (including the acceptance criteria) for
combining data obtained from Taqman qPCR and SYBR®-
Green qPCR analysis will have to be developed. Recently, a
strategy for the interpretation of such analysis using a so-
called “differential PCR approach” has been developed
[22]. Such analysis is, to date, not yet available for
CoSYPS and may require that the PCR amplification
efficiencies for the different qPCR methods are well
established and measurable in a single-well mode. Such
determination is not (yet) available in the standard PCR
programs of the PCR machines and requires considerable
time investment using other alternative PCR analysis
software [23].
GMP detection at low-level presence
A particular challenge for the EU legal system is the
asynchronous commercialization of GMP on the global
market. While segregation systems are put in place in the
GMP exporting countries, greatly reducing the probability
of escapes of non-EU authorized GMP in EU shipments,
accidents or occasional failure seem to be inevitable (e.g.
[3, 4]). Due to the zero-tolerance rules applied at the EU-
level for non-authorized substances, these escapes represent
illegal materials and are to be withdrawn from the EU
market. In most cases, these non-authorized substances are
present only as traces but are being observed in enforce-
ment and reported as such in the European RASFF system
(http://ec.europa.eu/food/food/rapidalert).
To monitor and manage the presence of substances at
such low levels, new screening strategies may have to be
implied based on analyzing more subsamples and more
targets within a single sample analysis. For a more detailed
discussion on some of the novel approaches that could be
applied for this purpose, we refer to Querci at al. [7]. It
remains, however, to be evaluated whether appropriate
validation schemes according to the ISO-standards can be
put into place for such low amounts of materials in a
sample applying these complex technologies.
To date, a combinatory matrix-based approach based on
simplex (eventually duplex or multiplex) qPCR methods in
a 96-well (or larger) format could also be envisaged for
such purposes as long as within the global GMP Universe,
common elements (such as the p35S, the GM-traits…) are
being applied in the transformation vectors. When GMP
become however more specialized using only unique DNA
sequences (as e.g., in the GM-maize LYO38 (1, 2, and 3)),
the advantage of a combinatory approach may become a
lesser efficient strategy.
An i-GMID platform: “twittering” technical tools
and decision support on the web
Finally, given the complexity of the GMP analysis, it is
preferred that a DSS such as that developed for CoSYPS,
be maintained and updated centrally (e.g., by the European
Commission or FAO) and made accessible through a web
application. Such on-line data interpretation of GMP
analytical results within a matrix-based DSS, should allow
for designing customized GMP-screening modules. Within
this set-up, access to DBases containing up-to-date infor-
mation on validated qPCR methods and available certified
reference materials should be included. Optimal combina-
tion of methods could be evaluated through “fuzzy logic”
principles as outlined by [24]. In addition, algorithms such
as the ‘GMOTrack” system recently developed by the
2122 M. Van den Bulcke et al.National Institute of Biology that enable the choice of the
better set of methods according to a number of sample
parameters (presence of target elements, frequency of
occurrence, and a cost function) could also be incorporated
(http://kt.ijs.si/software/GMOtrack/). Applying all these
decision-support principles within a web-based manner to
a GMP detection system, such as CoSYPS, may assist in
harmonizing and enabling transparency in GMP screening
analysis for all stakeholders in the field of GMP production,
processing, distribution, and control.
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